Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$32,383,812
in 18 filings, $13.4M under 10b5-1 plans

Net −$32,383,812. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-07-01 VIKING GLOBAL INVESTORS LP 10% owner Conversion +15,524,350 36,108,295
2019-07-01 VIKING GLOBAL INVESTORS LP 10% owner Conversion +2,007,740 38,116,035
2019-07-01 VIKING GLOBAL INVESTORS LP 10% owner Conversion +290,572 38,406,607
2019-07-01 VIKING GLOBAL INVESTORS LP 10% owner Conversion · Series D Preferred Stock −18,908,945 0
2019-07-01 VIKING GLOBAL INVESTORS LP 10% owner Conversion · Series E Preferred Stock −15,524,350 0
2019-07-01 VIKING GLOBAL INVESTORS LP 10% owner Conversion · Series F Preferred Stock −2,007,740 0
2019-07-01 VIKING GLOBAL INVESTORS LP 10% owner Conversion · Series F-1 Preferred Stock −290,572 0
2019-07-01 GOEL DAVID E. Director Conversion +200,000 200,000
2019-07-01 GOEL DAVID E. Director Conversion +5,893,716 6,093,716
2019-07-01 GOEL DAVID E. Director Conversion +11,154,116 17,247,832
2019-07-01 GOEL DAVID E. Director Conversion +84,359 17,332,191
2019-07-01 GOEL DAVID E. Director Conversion · Series A Convertible Preferred Stock −200,000 0
2019-07-01 GOEL DAVID E. Director Conversion · Series E-1 Convertible Preferred Stock −5,893,716 0
2019-07-01 GOEL DAVID E. Director Conversion · Series F Convertible Preferred Stock −11,154,116 0
2019-07-01 GOEL DAVID E. Director Conversion · Series F-1 Convertible Preferred Stock −84,359 0

Page 119 of 119 · 2,375 trades